glp 1 binge eating disorder The rapid rise of GLP-1 receptor agonists presents a complex dilemma for clinicians managing patients with disorders. While these medications show potential in reducing eating behaviors by targeting brain reward Ozempic, Wegovy: GLP-1s May Help

And it aligns naturally with how GLP-1 medications affect appetite, since most users find mornings are their least hungry period anyway

GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating glucose-dependent insulin secretion whilst simultaneously suppressing glucagon release from alpha cells

Common early side effects include nausea, reduced appetite, and gastrointestinal discomfort, which usually diminish as the body adapts

Voltage-independent calcium channels mediate slow oscillations of cytosolic calcium that are glucose-dependent in pancreatic beta-cells

They activate with water and use evaporative cooling to keep medication under 79F for 45+ hours

JCI Insight 5(16) Chan J, Scott R, Arjona Ferreira J, Sheng D, Gonzalez E, Davies M et al (2008) Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency